871-B1), Recombinant Mouse IGFBP-1 (Catalog #
1588-B1) and Recombinant Human IGFBP-5 (Catalog #
875-B5). PVDF Membrane was probed with 1 µg/mL of Mouse Anti-Human IGFBP-1 Monoclonal Antibody (Catalog # MAB675) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
HAF018). A specific band was detected for IGFBP-1 at approximately 26 kDa (as indicated). This experiment was conducted under non-reducing conditions and using
Immunoblot Buffer Group 3." class="big_lightbox">

871-B1), Recombinant Mouse IGFBP-1 (Catalog #
1588-B1) and Recombinant Human IGFBP-5 (Catalog #
875-B5). PVDF Membrane was probed with 1 µg/mL of Mouse Anti-Human IGFBP-1 Monoclonal Antibody (Catalog # MAB675) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
HAF018). A specific band was detected for IGFBP-1 at approximately 26 kDa (as indicated). This experiment was conducted under non-reducing conditions and using
Immunoblot Buffer Group 3." alt="Western blot shows 25 ng of Recombinant Human IGFBP-1 (Catalog #
871-B1), Recombinant Mouse IGFBP-1 (Catalog #
1588-B1) and Recombinant Human IGFBP-5 (Catalog #
875-B5). PVDF Membrane was probed with 1 µg/mL of Mouse Anti-Human IGFBP-1 Monoclonal Antibody (Catalog # MAB675) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog #
HAF018). A specific band was detected for IGFBP-1 at approximately 26 kDa (as indicated). This experiment was conducted under non-reducing conditions and using
Immunoblot Buffer Group 3." class="big_thumb" />
871-B1) inhibits Recombinant Human IGF-I (Catalog #
291-G1) induced proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IGF-I (6 ng/mL) activity elicited by Recombinant Human IGFBP-1 (5 µg/mL) is neutralized (green line) by increasing concentrations of Human IGFBP-1 Monoclonal Antibody (Catalog # MAB675). The ND
50 is typically 10-40 µg/mL." class="big_lightbox">

871-B1) inhibits Recombinant Human IGF-I (Catalog #
291-G1) induced proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IGF-I (6 ng/mL) activity elicited by Recombinant Human IGFBP-1 (5 µg/mL) is neutralized (green line) by increasing concentrations of Human IGFBP-1 Monoclonal Antibody (Catalog # MAB675). The ND
50 is typically 10-40 µg/mL." class="big_thumb" />
871-B1) was serially diluted and captured by Mouse Anti-Human IGFBP‑1 Monoclonal Antibody (Catalog # MAB675) coated on a Clear Polystyrene Microplate (Catalog #
DY990). Goat Anti-Human IGFBP‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog #
AF871) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog #
DY998)" class="big_lightbox">

871-B1) was serially diluted and captured by Mouse Anti-Human IGFBP‑1 Monoclonal Antibody (Catalog # MAB675) coated on a Clear Polystyrene Microplate (Catalog #
DY990). Goat Anti-Human IGFBP‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog #
AF871) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog #
DY998)" class="big_thumb" />